Matthew A. Gubens, MD, on Non–Small Cell Lung Cancer: Is There Still a Role for Chemotherapy?

Posted: Sunday, April 7, 2019

Matthew A. Gubens, MD, of the UCSF Helen Diller Family Comprehensive Cancer Center, discusses the increasing use of immune checkpoint inhibitors, therapeutic vaccines, and adoptive T-cell therapy for non–small cell lung cancer, and how chemotherapy will fit into the treatment armamentarium.